+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Registries and randomised controlled trials in pulmonary arterial hypertension: are they revealing?



Registries and randomised controlled trials in pulmonary arterial hypertension: are they revealing?



International Journal of Clinical Practice. Supplement 2011(168): 1-2




(PDF emailed within 0-6 h: $19.90)

Accession: 055446471

Download citation: RISBibTeXText

PMID: 20939839

DOI: 10.1111/j.1742-1241.2010.02527.x


Related references

Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials. Annals of the Rheumatic Diseases 67(6): 808-814, 2007

Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials. Chest 150(2): 353-366, 2017

Efficacy and Safety of Statins for Pulmonary Hypertension: A Meta-Analysis of Randomised Controlled Trials. Heart, Lung and Circulation 26(5): 425-432, 2016

Do we need controlled clinical trials in pulmonary arterial hypertension?. European Respiratory Journal 17(1): 1-3, 2001

Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension. European Respiratory Journal 50(3), 2018

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. European Heart Journal 30(4): 394-403, 2009

Systematic review of randomised, double-blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension. International Journal of Clinical Practice 61(10): 1756-1765, 2007

Meta-analysis of randomized controlled trials on the treatment of pulmonary arterial hypertension. Circulation Journal 74(11): 2503; Author Reply 2504, 2010

Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension. Circulation Journal 74(7): 1458-1464, 2010

Complementarity between randomised controlled trials and observational registries : the example of cardiovascular prevention with SGLT2 inhibitors. Revue Medicale de Liege 72(12): 563-568, 2018

O-024Outcome Research In 77 Patients With Pulmonary Arterial Hypertension Receiving Sildenafil: A Double-blind, Randomised Controlled Study. Archives of Disease in Childhood 99(Suppl 2): A31.1-A31, 2014

STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials. Journal of Cardiovascular Pharmacology 44 Suppl 1: S80-S84, 2005

STRIDE 1: Effects of the selective ETA receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials. Journal of Cardiovascular Pharmacology 44(Suppl. 1): S80-S84, 2004

Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension. Korean Journal of Internal Medicine 28(6): 701-707, 2014

Major discrepancies between what clinical trial registries record and paediatric randomised controlled trials publish. Trials 17(1): 430, 2016